These results demonstrated that PSVII@MCP-CaP inhibited the migration and invasion of colon cancer cells by decreasing the protein expression of CD44, MMP-9 and N-cadherin, while increasing the protein expression of E-cadherin. Here, MMP9 is linked to colonic neoplasm.